26th January 2024

A 72-year-old male diagnosed with polymyalgia rheumatica is commenced on high-dose oral steroid therapy.

A 72-year-old male diagnosed with polymyalgia rheumatica is commenced on high-dose oral steroid therapy. He is due to continue this treatment for one year and is commenced on oral calcium and vitamin D supplementation. He is otherwise fit and well and does not suffer from any other medical conditions. His routine blood test results were within normal parameters. 

In terms of assessing his fracture risk, what is the next best step in management? 

Select the SINGLE most appropriate option from the list below. Select ONE option only.